Abstract: A battery pack mounting structure for vehicles, includes a frame side member extending in a front and rear direction on each side of a vehicle to form a chassis frame, a battery disposed to be overlapped horizontally on inside of both frame side members, and a battery case enclosing the battery therein, wherein a case side portion provided on a side of the battery case is coupled to a lower side of the frame side member.

Abstract: Disclosed are a pressure sensor using conductive thread, the pressure sensor including a plurality of first conductive lines arranged parallel to each other in a first direction in a state of being spaced apart from each other, a plurality of second conductive lines arranged parallel to each other in a second direction intersecting the first direction in a state of being spaced apart from each other, and a spacer located between the plurality of first conductive lines and the plurality of second conductive lines, resistance of the spacer being changed when pressure is applied thereto, whereby it is possible to measure a wide range of pressure with elasticity and flexibility, and a method of manufacturing the same.

Abstract: The present disclosure includes a frame side member forming a chassis frame and disposed on both sides of a vehicle in a forward-backward direction, a battery disposed to overlap inwardly from the frame side member in a horizontal direction, and a battery case surrounding the battery and coupled to the frame side member, wherein a cross section of the frame side member forms a plurality of closed spaces.

Abstract: Provided is a cooling device capable of controlling the temperature of an upper portion of a reactor, or more particularly, a gas supply device, for example, a shower head. The cooling device includes a separator configured to uniformly and efficiently cool the gas supply device.

Abstract: The present invention relates to the pharmaceutical use of FAM19A5 involved in regulating gliogenesis, and more specifically, to the use of FAM19A5 in the prevention, diagnosis, or treatment of central nervous system injuries, degenerative brain diseases, or central nervous system diseases, FAM19A5 being spread in the neural stem cells in vertebrates and regulating gliogenesis.

Abstract: In one example, a semiconductor device comprises a redistribution layer (RDL) substrate having a top surface and a bottom surface, wherein the RDL substrate comprises a filler-free dielectric material, an electronic device on the top surface of the RDL substrate, an electrical interconnect on the bottom surface of the RDL substrate and electrically coupled to the electronic device, a first protective material contacting a side surface of the electronic device and the top surface of the RDL substrate, and a second protective material contacting a side surface of the electrical interconnect and the bottom surface of the RDL substrate. Other examples and related methods are also disclosed herein.

Abstract: A display device includes: a substrate; a display element on the substrate; a capping layer on the display element; and a thin film encapsulation layer on the capping layer, wherein the capping layer includes: a first capping layer on the display element; a second capping layer on the first capping layer, the second capping layer having a refractive index greater than that of the first capping layer; and a third capping layer on the second capping layer, the third capping layer having a refractive index smaller than that of the second capping layer, wherein the second capping layer has a thickness of 30 nanometers (nm) to 60 nm.

Abstract: An embodiment structural battery for an electric vehicle includes an upper rail and a lower rail coupled with the upper rail, wherein the upper rail and the lower rail are electrically connected with each other by a terminal and a wiring, so that the upper rail and the lower rail electrically connected with each other serve as both the structural battery and a roof rail of a vehicle body.

Abstract: An embodiment structural battery for an electric vehicle includes a plurality of cells stacked on each other, each of the plurality of cells including a positive electrode layer, an electrolyte layer, and a negative electrode layer stacked with the electrolyte layer between the positive and negative electrodes, wherein the plurality of cells define a battery by electrical connection of a positive electrode terminal and a negative electrode terminal respectively provided in the plurality of cells, structure reinforcement layers stacked on each of an outermost upper layer and an outermost lower layer of the plurality of cells, and carbon fiber current collecting layers stacked between each of the structure reinforcement layers and the plurality of cells.

Abstract: The present invention relates to a device and method for implementing dynamic-service-oriented communication between vehicle applications on an AUTomotive Open System ARchitecture (AUTOSAR) adaptive platform (AP). A machine including an electronic control unit (ECU) to which the portable operating system interface (POSIX) operating system (OS) is ported and implementing dynamic-service-oriented communication between vehicle applications on an AUTOSAR AP includes a skeleton which is an application for providing a service on the platform, a proxy which is an application using the service on the platform, and a service communication management (CM) which is an application for brokering service-oriented communication between vehicle applications on the platform.

Abstract: A camera module is provided. The camera module includes a lens module including one or more lenses; an image sensor configured to convert light passing through the lens module into an electrical signal; and a filter configured to perform a polarization function, wherein the filter is configured to be movable in a space formed between the lens module and the image sensor.

Abstract: A display device includes a first display substrate including a light emitting element which emits light of a first color or light of a second color different from the first color, a second display substrate including in order toward the first display substrate, a layer including both a bank layer defining an opening and a wavelength control pattern in the opening, a capping layer covering the wavelength control pattern and the bank layer, and a color absorbing layer which corresponds to the bank layer and blocks the light of the first color and the light of the second color. The capping layer includes a first area corresponding to the color absorbing layer, the bank layer includes a second area corresponding to the color absorbing layer, and the first area of the capping layer is between the color absorbing layer and the second area of the bank layer.

Abstract: A method of detecting a biomolecule, a computing device performing the method, and a biomolecule detection system therefor are provided. The method includes receiving a terahertz signal that passed deionized water or reference material, receiving a terahertz signal that passed a target including a predetermined biomolecule, extracting a digital modulation characteristic for the received terahertz signal that passed the deionized water and the received terahertz signal that passed the target, and detecting the predetermined biomolecule included in the target by analyzing the extracted digital modulation characteristic, wherein the received terahertz signal that passed the deionized water and the received terahertz signal that passed the target are generated using a digitally modulated optical signal based on a transmission speed determined based on kinematics of the predetermined biomolecule.

Abstract: Disclosed is a display device including a display panel that displays an image on a display surface and an input sensor having a sensor area and a dummy area defined therein. The input sensor includes a first conductive layer that is disposed on the display panel and that includes a first dummy electrode disposed in the sensor area and the dummy area, a second conductive layer that is disposed on the first conductive layer and that includes a sensor electrode disposed in the sensor area and a second dummy electrode disposed in the dummy area, and a pressure sensor electrode disposed between the first dummy electrode and the second dummy electrode.

Abstract: The gas sensor according to an exemplary embodiment of the present invention comprises: an FET device including one or more gate electrodes; a sensor array part including a plurality of sensors, in which a first electrode of each sensor is connected to at least one gate electrode of the plurality of gate electrodes in the FET device; and a controller detecting a gas using a current between a drain-source in response to voltage changes in the gate electrode of the FET device, wherein each sensor includes: a first electrode connected to a gate electrode of the FET device; a second electrode receiving an operating voltage through a switch controlled by the controller; and a detection film interposed between the first electrode and the second electrode.

Abstract: The present invention provides a device for measuring biological information including a sensor array, wherein the sensor array includes a plurality of sensors that are either sensors for amplifying photoreactivity or sensors forming an island network connected by a plurality of multi-channels and, in the device, the average value of biological information about the skin tissues is measured based on values output from the sensor array, and a method of measuring biological information using the device.

Abstract: A use of a fusion protein of a therapeutic enzyme and an immunoglobulin Fe region is disclosed. The fusion protein is represented by the following chemical formula 1. The fusion protein shows protective effects on peripheral sensory nerves and exhibits an extended duration in the body. Thus, the fusion protein or a composition containing the fusion protein can be used in the prevention or improvement of neuropathy.

Abstract: Provided are a GIP derivative, a pharmaceutically acceptable salt or solvate thereof, or a long-acting conjugate thereof, or a pharmaceutical composition including the same for preventing or treating inflammatory or autoimmune disease.

Abstract: Provided is a pharmaceutical composition for preventing or treating vasculitis, including a glucagon/GLP-1/GIP triple agonist, a pharmaceutically acceptable salt thereof, a solvate thereof, or a long-acting conjugate thereof.

Abstract: The present invention relates to the pharmaceutical use of FAM19A5 involved in regulating gliogenesis, and more specifically, to the use of FAM19A5 in the prevention, diagnosis, or treatment of central nervous system injuries, degenerative brain diseases, or central nervous system diseases, FAM19A5 being spread in the neural stem cells in vertebrates and regulating gliogenesis.